Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis.

"Disclosure statement : R.H. is an employee at Boehringer Ingelheim AB. M.W., V.H., K.A. and D.M.W. declare no conflicts of interest regarding this study."

"Funding This work was supported by the Crafoord foundation [20160537]; the Greta and Johan Kock foundation [230_20211006_032]; the Alfred Österlund foundation; King Gustaf V’s 80th Birthday Fund [FAI-2020–0651]; the Donation fund at the Department of Rheumatology, Lund University Hospital, Sweden; the Medical Faculty of the University of Lund, Sweden Sweden [2018-Projekt0044 and 2021-YT0014]; and the Swedish Rheumatism Association [R-754211 and R-747741]. Disclosure statement: R.H. is an employee at Boehringer Ingelheim AB. M.W., V.H., K.A. and D.M.W. declare no conflicts of interest regarding this study."